Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads

Medicinal Research Reviews

Volumn 28, Issue 5, 2008, Pages 746-772

  Negi, Arvind S ^a   Kumar, J K ^a   Luqman, Suaib ^a   Shanker, Karuna ^a   Gupta, M M ^a   Khanuja, S P S ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

Author keywords

Andrographolide; Curcumin; Glycyrrhizin; Hepatoprotective; Hypophyllanthin; Kutkoside; Neoandrographolide; Phyllanthin; Picroside; Silymarin

Indexed keywords

ANDROGRAPHOLIDE; BERBERINE; CAFESTOL; CAFFEIC ACID; CLEOME VISCOSA EXTRACT; CURCUMIN; EMODIN; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; HYPOPHYLLANTHIN; KAHWEOL; KOLAVIRON; KUTKIN; LEAD; LUPEOL; MYRISTICIN; NEOANDROGRAPHOLIDE; OLEANOLIC ACID; PARACETAMOL; PHYLLANTHIN; PLANT EXTRACT; QUERCETIN; RUBIADIN; SCHIZANDRIN B; SILYMARIN; THYMOQUINONE; TILIROSIDE; UNCLASSIFIED DRUG; URSOLIC ACID;

DRUG ELIMINATION; DRUG STRUCTURE; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; MEDICINAL PLANT; NONHUMAN; REVIEW;

ANIMALS; CINNAMATES; CURCUMIN; CYTOKINES; DITERPENES; GLUCOSIDES; GLYCYRRHIZIC ACID; HUMANS; LIGNANS; LIVER; LIVER DISEASES; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS; PROTECTIVE AGENTS; SILYMARIN; TETRAHYDRONAPHTHALENES;

EID: 50249134405     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.20115     Document Type: Review

References (179)

1. WHO fact sheet No. 164 and 204, October 2000.
2. NIDDK/NIH. An action plan for liver disease research http://liverplan. niddk.nih.gov.
3. Tome S, Lucey MR. Review article: Current management of alcoholic liver disease. Aliment Pharmacol Ther 2004;19:707-714.
4. Wiart C, Kumar K, Yusof MY, Hamimah H, Fauzi ZM, Sulaiman M. Antiviral properties of Ent-labdene diterpenes of Andrographis paniculata Nees, inhibitors of herpes simplex virus type 1. Phytother Res 2005;19:1069-1070.
5. Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, Aggarwal BB. Role of prooxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007;43:568-580.
6. Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs 2001;61:2035-2063.
7. Flora K, Hahn M, Rosen H, Benner K. Milk Thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998;93:139-143.
8. Blumenthal M, Ferrier GKL, Cavaliere C. Total sales of herbal supplements in United States show steady growth. Herbal Gram 2006;71:64-66.
9. Wagner H, Seligmann O. Liver therapeutic drugs from Silybum marianum. In: Chang HM, Yeung HW, Tso WW, Koo A, editors. Advances in Chinese Medicinal Materials Research. Singapore: World Scientific Publ. Co.; 1985.
10. Chavez ML. Treatment of hepatitis C with milk thistle? J Herb Pharmacother 2001;1:79-90.
11. Duan L, Carrier DJ, Clausen EC. Silymarin extraction from milk thistle using hot water. Appl Biochem Biotechnol 2004;114:559-568.
12. Leng-Peschlow E. Properties and medical use of flavanolignans (Silymarin) from Silybum marianum. Phytother Res 1996;10 (Suppl 1):S25-S26.
13. Kvasnicka F, Biba B, Sevcik R, Voldrich M, Kratka J. Analysis of the active components of silymarin. J Chromatogr A 2003;990:239-245.
14. Lee JI, Hsu BH, Wu D, Barrett JS. Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 2006; 57-68.
15. Blumenthal M Sr, editor. Herbal medicine: Expanded commission E monographs. 1st edition. Newton, MA: Integrative Med Commun; 2000. pp 257-263.
16. 4-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol 1989;3:183-191.
17. Fraschini F, Demartini G, Esposti D. Pharmacology of silymarin. Clin Drug Invest 2002;22(1):51-65.
18. Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies in IdB 1016, a silybinphosphatiddylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet 1990;15:333-338.
19. Orlando R, Fragasso A, Lampertico M, et al. Silybin kinetics in patients with liver cirrhosis: A comparative study of a silybin-phosphatidylcholine complex and silymarin. Med Sci Res 1990;18:861-863.
20. Flory PJ, Krug G, Lorenz D, Mennicke WH. Studies on elimination of silymarin in cholecystectomized patients. I. Biliary and renal elimination after a single oral dose. Planta Med 1980;38:227-237.
21. Schandalik R, Gatti G, Perucca E. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Arzneimittelforschung 1992;42:964-968.
22. Buzzelli G, Moscarella S, Giusti A, Duchini A, Marena C, Lampertico M. A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis. Int J Clin Pharmacol Ther Toxicol 1993;31(9):456-460.
23. Magliulo E, Gagliardi B, Fiori GP. Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres. Med Klin 1978;73(28-29):1060-1065.
24. Kiesewetter E, Leodolter I, Thaler H. Results of two double blind studies on the effect of silymarin in chronic hepatitis. Leber Magen Darm 1977;7(5):318-323.
25. Valenzuela A, Lagos C, Schmidt K, Videla LA. Silymarin protection against hepatic lipid peroxidation by acute ethanol intoxication in the rat. Biochem Phramacol 1985;34:2209-2212.
26. Fraschini F, Demartini G, Esposti D. Pharmacology of silymarin. Clin Drug Invest 2002;22(1):51-65.
27. Dehmlow C, Erhard J, de Groot H. Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silybinin. Hepatol 1996;23:749-754.
28. Miguez MP, Anundi I, Sainz-Pardo LA, Lindros KO. Hepatoprotective mechanism of silymarin: No evidence for involvement of cytochrome P 450 2 E1. Chem Biol Interact 1994;91:51-63.
29. Feher J, Lang I, Nekam K, Muzes G, Deak G. Effect of free radical scavengers on superoxide dismutase (SOD) enzyme in patients with alcoholic cirrhosis. Acta Med Hung 1988;45:265-276.
30. Varga Z, Czompa A, Kakuk G, Antus S. Inhibition of the superoxide anion release and hydrogen peroxide formation in PMNLs by flavanolignans. Phytother Res 2001;15:608-612.
31. Beckmann-Knopp S, Reitbrock S, Weyhenmeyer R, et al. Inhibitory effects of silybinin on cytochrome P450 enzymes in human liver microsomes. Pharmcol Toxicol 2000;86:250-256.
32. Saller R, Melzer J, Reichling J, Brignoli R, Meier R. An updated systematic review of the pharmacology of silymarin. Forsch Komplementarmed 2007;14(2)70-80.
33. Flora K, Hahn M, Rosen H, Benner K. Milk Thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998;93:139-143.
34. Kang JS, Jeon YJ, Kim HM, Han SH, Yang KH. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 2002;320:138-144.
35. Fraschini F, Demartini G, Esposti D. Pharmacology of Silymarin. Clin Drug Investig 2002;22(1):51-65.
36. Adverse Drug Reactions Advisory Committee. An adverse reaction to the herbal medication milk thistle (Silybum marianum). Med J Aust 1999;170:218-219.
37. Pares A, Planas R, Torres M, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: Results of a controlled, double blind, randomized and multicentre trial. J Hepatol 1998;28:615-621.
38. Puri A, Saxena A, Saxena RP, Saxena KC, Srivastava V, Tandon JS. Immuno-stimulant agents from Andrographis paniculata. J Nat Prod 1993;56:995-999.
39. Visen PKS, Shukla B, Patnaik GK, Dhawan BN. Andrographolide protects rat hepatocytes against paracetamol-induced damage. J Ethnopharmacol 1993;40(2):131-136.
40. Handa SS, Sharma A. Hepatoprotective activity of andrographolide from Andrographis paniculata against carbon tetrachloride. Ind J Med Res 1990;92:276-283.
41. Handa SS, Sharma A. Hepatoprotective activity of andrographolide from Andrographis paniculata against galactosamine and paracetamol intoxication in rats. Ind J Med Res 1990;92:284-292.
42. Choudhury BR, Haque SJ, Poddar MK. In vitro and in vivo effects of kalmegh (Andrographis paniculata) extract and andrographolide on hepatic microsomal drug metabolizing enzymes. Planta Med 1987;53:135-140.
43. Medford CJ, Chang RS, Chen GQ, Olmstead MM, Smith KM. A Conformational Study of Diterpenoid Lactones Isolated From the Chinese Medicinal Herb Andrographis paniculata. J Chem Soc Perkin Trans II 1990;2:1011-1016.
44. Chan WR, Willis C, Cava MP, Stein RP. Stereochemistry of andrographolide. Chem Ind 1963;12:495.
45. Rajani M, Shrivastava N, Ravishankara MN. A rapid method for isolation of andrographolide from Andrographis paniculata Nees (Kalmegh). Pharm Biol 2000;38:204-209.
46. Akowuah GA, Zhari A, Norhayati I, Mariam A. HPLC and HPTLC densitometric determination of andrographolides and antioxidant potential of Andrographis paniculata. J Food Composit Anal 2006;19:118-126.
47. Saxena S, Jain DC, Gupta MM, Bhakuni RS, Mishra HO, Sharma RP. High-performance thin-layer chromatographic analysis of hepatoprotective diterpenoids from Andrographis paniculata. Phytochem Anal 2000;11:34-36.
48. Du Q, Jerz G, Winterhalter PJ. Separation of andrographolide and neoandrographolide from the leaves of Andrographis paniculata using high-speed counter-current chromatography. J Chromatogr A 2003;984:147-151.
49. Ruengsitagoon W, Anuntakarun K, Aromdee C. Flow injection spectrophotometric determination of andrographolide from Andrographis paniculata. Talanta 2006;69:900-905.
50. Rastogi RP. editor. Compendium of Indian Medicinal Plants. 1998;5:53-54.
51. Choudhury BR, Poddar MK. Andrographolide and kalmegh (A. paniculata) extract: Effect on rat liver and serum transminase. IRCS J Med Sci 1984;12:466-467.
52. Visen PKS, Shukla B, Patnaik GK, Dhawan BN. Andrographolide protects rat hepatocytes against paracetamol induced damage. J Ethnopharmacol 1993;40(2):131-136.
53. Kapoor NK, Chander R, Srivastava V, Tandon JS. Antihepatotoxic activity of diterpenes of Andrographis paniculata (Kal-Megh) against Plasmodium berghei-induced hepatic damage in Mastomys natalensis. Int J Phramacog 1995;33(2):135-138.
54. Shukla B, Visen PK, Patnaik GK, Dhawan BN. Choleretic effect of andrographolide in rats and guinea pigs. Planta Med 1992;58(2):146-149.
55. He X, Li J, Gao H, Qui F, Cui X, Yao X. Four new andrographolide metabolites in rats. Tetrahedron 2003;59:6603-6607.
56. Kapil A, Koul IB, Banerjee SK, Gupta BD. Antihepatotoxic effects of major diterpenoid constituents of Andrographis paniculata. Biochem Pharmacol 1993;46:182-185.
57. Kamdem RE, Sang S, Ho CT. Mechanism of the superoxide scavenging activity of neoandrographolide - A natural product from Andrographolide paniculata Nees. J Agric Food Chem 2002;50:4662-4665.
58. Chang HM, But PPH, editors. Pharmacology and applications of Chinese Material Medica, Vol. 1-2. Singapore: World Scientific Publishing Company; 1986.
59. Wang YH. The pharmacology and applications of traditional Chinese medicine. Beijing: People's Health Press; 827 p.
60. Song EK, Cho H, Kim JS, Kim NY, An NH, Kim JA, Lee SH, Kim YC. Diarylheptanoids with free radical scavenging and hepatoprotective activity in vitro from Curcuma longa. Planta Med 2001;67:876-877.
61. Payton F, Sandusky P, Alworth WL. NMR study of solution structure of curcumin. J Nat Prod 2007;70:143-146.
62. Anderson AM, Mitchell MS, Mohan RS. Isolation of curcumin from turmeric. J Chem Educ 2000;77(3):359-360.
63. 2. Part 1. The case of curcumin. Braz J Chem Eng 2000; 323-328.
64. Dandekar DV, Gaikar VG. Microwave assisted extraction of curcuminoids from curcuma longa. Separation Sci Technol 2002;37:2669-2690.
65. Dandekar DV, Gaikar VG. Hydrotopic extraction of curcuminoids from turmeric. Separation Sci Technol 2003;38:1185-1215.
66. Patel K, Krishna K, Sokoloski E, Ito Y. Preparative separation of curcuminoids from crude curcumin and turmeric powder by pH-zone refining countercurrent chromatography. J Liquid Chromatogr Relat Technol 2000;23:2209-2218.
67. WHO food additive series. Rome 1976;7:75-78.
68. Jayaprakasha GK, JagamohanRao L, Sakariah KK. An improved HPLC method for the determination of curcumin, demethoxy curcumin and bisdemethoxy curcumin. J Agric Food Chem 2002;50:3668-3672.
69. Health DD, Pruitt MA, Brenner DE, Rock CL. Curcumin in plasma and urine: Quantitation by high performance liquid chromatography. J Chromatogr B 2003;783:287-295.
70. Inoue K, Hamasaki S, Yoshimura Y, Yamada M, Nakamura M, Ito Y, et al. Validation of LC/electrospray-MS for determination of major curcuminoids in foods. J Liquid Chromatogr Relat Technol 2003;26:53-62.
71. Kiso Y, Suzuki Y, Watanabe N, Oshima Y, Hikino H. 1983; Antihepatotoxic principles of Curcuma longa rhizomes. Planta Med 1983;49:185-187.
72. Sugiyama T, Nagata J, Yamagishi A, Endoh K, Saitoh M, Yamada K, Yamada S, Umegaki K. Selective protection of curcumin against carbon tetrachloride- induced inactivation of hepatic cytochrome P450 isozymes in rats. Life Sci 2006;78(19):2188-2193.
73. Akila G, Rajakrishnan V, Vishwanathan P, Rajshekaran KN, Menon VP. Effects of curcumin on lipid profile and lipid peroxidation status in experimental hepatic fibrosis. Hepatol Res 1998;11(3):147-157.
74. Zima T, Fialova L, Mestet O, Janeboua M, Crkovska J, Malbohan I, Stipek S, Mikulikova L, Popor P. Oxidative stress, metabolism of ethanol and alcohol related diseases. J Biomed Sci 2001;8:59-70.
75. Naik RS, Mujumdar AM, Ghaskabi S. Protection of liver cells from ethanol cytotoxicity by Curcumin in liver slice culture in vitro. J Ethnopharmacol 2004;95:31-37.
76. 1) cell injury. Free Rad Biol Med 1998;24:49-54.
77. Rajkrishnan K, Pandurangan AG, Pushpangadan P. Protective role of Curcumin in ethanol toxicity. Phytother Res 1998;12:55-56.
78. Rajkrishnan V, Jayadeep A, Arun OS, Sudhakaran PR, Menon VP. Changes in the prostaglandin levels in alcohol toxicity: Effect of curcumin and N-acetylcysteine. J Nutr Biochem 2000;11:509-514.
79. Soudamini KK, Unnikrishnan MC, Soni KB, Kuttan R. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Ind J Physiol Pharmacol 1992;365:239-243.
80. Wahlstrom BO, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol 1978;43:86-92.
81. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabol Depos 1999;27:486-494.
82. Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadien-3,5-dione) in the rat. Xenobiotica 1978;8:761-776.
83. Toda S, Miyase T, Arichi H, Tanizawa H, Takino Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem Pharm Bull 1985;33:1725-1728.
84. Manikandan P, Sumitra M, Aishwarya S, Manohar BM, Lokanadam B, Puvanakrishnan R. Curcumin modulates free radical quenching in myocardial ischaemia in rats. Int J Biochem Cell Biol 2004;36(10):1967-1980.
85. Pulla Reddy ACH, Lokesh BR. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous ion. Mol Cell Biochem 1994;137:1-8.
86. Unnikrishnan MK, Rao MN. Curcumin inhibits nitrogen dioxide induced oxidation of haemoglobin. Mol Cell Biochem 1995;146:35-37.
87. 2) quencher. Biochem Biophys Res Commun 2002;295:62-66.
88. Oetari S, Sudibyo M, Commandeur JNM, Samhoeddi R, Vermeulen NPE. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol 1996;51:39-45.
89. Pari L, Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate induced hepatotoxicity. Pharmacol Res 2004;49:481-486.
90. Sun YM, Zhang HY, Chen DZ, Liu CB. Theoretical elucidation on the antioxidant mechanism of curcumin: A DFT study. Org Lett 2002;4:2909-2911.
91. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991;57(1):1-7.
92. Handa SS, Sharma A, Chakrabarti KK. Natural products and plants as liver protecting drugs. Fitoterapia 1986;57:503-512.
93. Aswal BS, Chandra R, Chatterjee SK, Dhawan BN, Dwivedi Y, Garg NK, Jain P, Kapoor NK, Kulshreshtha DK, Mehrotra BN, Patnaik GK, Rastogi R, Sarin JPS, Saxena KC, Sharma SC, Shukla B, Visen PKS. Ind. Patent File No. 450/de1/90.
94. Gupta PP. Picroliv. Drugs Fut 2001;26(1):25-31.
95. Kitagawa I, Hino K, Nishimura T, Kukai E, Yoshioka I, Inouye H, Yoshida T. Picroside I: A bitter principle of Picrorrhiza kurroa. Tetrahedron Lett 1969;43:3837-3840.
96. Singh B, Rastogi RP. Chemical examination of Picrorrhiza kurroa Benth. Part VI. Reinvestigation of kutkin. Ind J Chem 1972;10:29-31.
97. Dwivedi AK, Chaudhury M, Sarin JPS. Quantitative determination of picroside I and kutkoside in kutkin by TLC. Ind J Pharm Sci 1989;51:23-25.
98. Dwivedi AK, Chaudhury R, Seth RK, Sarin JPS. Simultaneous micro-determination of picroside-I and kutkoside in picroliv (Kutkin) by high performance liquid chromatography. Ind J Pharmac Sci 1989;51:274-275.
99. Vipul K, Nitin M, Gupta RC. A sensitive and selective LC-MS-MS method for simultaneous determination of picroside-I and kutkoside (active principles of herbal preparation picroliv) using solid phase extraction in rabbit plasma: Application to pharmacokinetic study. J Chromatogr B 2005;820(2):221-227.
100. Dhawan BN. Picroliv-A new hepatoprotective agent from an Indian medicinal plant, Picrorrhiza kurroa. Med Chem Res 1995;21:1194-1201.
101. Visen PKS, Shukla B, Patnaik GK, Kaul S, Kapoor NK, Dhawan BN. Hepatoprotective activity of active principle of Picrorrhiza kurroa on rat hepatocytes against paracetamol toxicity. Drug Dev Res 1991;22:209.
102. Dwivedi Y, Rastogi R, Garg NK, Dhawan BN. Prevention of paracetamol induced hepatic damage in rats by Picroliv, the standardized active fraction from Picrorrhiza kurroa. Phytother Res 1991;5:115-119.
103. Dwivedi Y, Rastogi R, Chander R, Sharma SK, Kapoor NK, Garg NK, Dhawan BN. Hepatoprotective activity of Picroliv against carbon tetrachloride-induced liver damaged in rats. Ind J Med Res 1990;92:195-200.
104. Saraswat B, Visen PKS, Patnaik GK, Dhawan BN. Anticholestatic effect of Picroliv, active hepatoprotective principle of Picrorrhiza kurroa, against carbon tetrachloride induced cholestasis. Ind J Exp Biol 1993;31:316-318.
105. Visen PKS, Shukla B, Patnaik GK, Chandra R, Singh V Kapoor NK, Dhawan BN. Hepatoprotective activity of Picroliv isolated from Picrorrhiza kurroa against thioacetamide toxicity on rat hepatocytes. Phytother Res 1991;5:224-227.
106. Saraswat B, Visen PKS, Patnaik GK, Dhawan BN. Reversal of thioacetamide induced cholestasis by Picroliv in rhodent. Phytother Res 1992;6:53-55.
107. Dwivedi Y, Rastogi R, Sharma SK, Garg NK, Dhawan BN. Picroliv affords protection against thioacetamide-induced hepatic damage in rats. Planta Med 1991;57:25-28.
108. Dwivedi Y, Rastogi R, Garg NK, Dhawan BN. Picroliv and its components kutkoside and picroside I protect liver against galactosamine-induced damage in rats. Pharmacol Toxicol 1992;71:383-387.
109. Visen PKS, Shukla B, Patnaik GK, Dhawan BN. Prevention of galactosamine induced hepatic damage by picroliv: Study on bile flow and isolated hepatocytes (ex vivo). Planta Med 1993;59:37-41.
110. Visen PKS, Saraswat B, Patnaik GK, Agarwal DP, Dhawan BN. Protective activity of Picroliv, isolated from Picrorrhiza kurroa against ethanol toxicity in isolated rat hepatocytes. Ind J Pharmacol 1996;28:98.
111. Saraswat B, Visen PKS, Patnaik GK, Dhawan BN. Ex vivo and in vivo investigations of picroliv from Picrorrhiza kurroa in an alcohol intoxication model in rats. J Ethnopharmacol 1999;66:263-269.
112. Rastogi R, Saksena S, Garg NK, Kapoor NK, Agarwal DP, Dhawan BN. Picroliv protects against alcohol-induced chronic hepatotoxicity in rats. Planta Med 1996;62:283-285.
113. Saksena S, Rastogi R, Garg NK, Dhawan BN. Rifampicin induced hepatotoxicity in rats: Protective effect of picroliv. Drug Dev Res 1994;33:46-50.
114. Chaturvedi GN, Singh RH. Jaundice of infective hepatitis A and its treatment with an indigenous drug Picrorrhiza kurroa: Review of 30 cases and clinical trial. J Ind Med 1966;1:1.
115. Khanna AK, Chander R, Kapoor NK, Dhawan BN. Hypolipidaemic activity of picroliv in albino rats. Phytother Res 1994;8:403-407.
116. Kumar RNV, Kuttan R. Inhibition of hepatocarcinogenesis by picroliv. Ind J Pharmacol 2000;32:135.
117. Singh V, Visen PKS, Patnaik GK, Kapoor NK, Dhawan BN. Effect of picroliv on low density lipoprotein receptor binding of rat hepatocytes in hepatic damage induced by paracetamol. Ind J Biochem Biophys 1992;29:428-432.
118. Chander R, Kapoor NK, Dhawan BN. Picroliv, picroside-I and kutkoside from Picrorrhiza kurroa are scavengers of superoxide anions. Biochem Pharmacol 1992;44:180-183.
119. Chander R, Kapoor NK, Dhawan BN. Effect of Picroliv on glutathione metabolism in liver and brain of Mastomys natalensis infected with Plasmodium berghei. Ind J Exp Biol 1992;30:711-714.
120. Srivastava S, Srivastava AK, Patnaik GK, Dhawan BN. Effect of Picroliv on liver regeneration in rats. Fitoterapia 1996;67:252-256.
121. Rastogi R, Saksena S, Garg NK, Dhawan BN. Effect of Picroliv on antioxidant system in liver of rats, after partial hepatectomy. Phytother Res 1995;9:364-367.
122. Sethi N, Singh RK, Sinha N, Bhatia G, Srivastava S, Roy AK. Safety evaluation studies on a new hepatoprotective agent picroliv in rats and monkeys. Biol Memoirs 1991;17:57.
123. Gaur SPS, Asthana OP, Sircar AR. Picroliv (a new hepatoprotective agent): First clinical impression. Ind J Pharmacol 2000;32:163.
124. Krishnamurthi GV, Seshadri TR. Phyllanthin from plant Phyllanthus. Proc Indian Acad Sci 1946;24:357-362.
125. Row LR, Srinivasulu C, Smith M, SubbaRao GSR. New lignans from Phyllanthus niruri Linn - The constitution of phyllanthin. Tetrahedron 1966;22(8):2899-2908.
126. Row LR, Satyanarayana P, Subba Rao GSR. Crystalline constituents of euphorbiaceae-IV: The synthesis and absolute configuration of phyllanthin. Tetrahedron 1967;23(4):1915-1918.
127. 13C-NMR assignments of phyllanthin and hypophyllanthin: Lignans that enhance cytotoxic responses with cultured multidrug resistance cells. J Nat Prod 1993;56(2):233-239.
128. Rajakannan V, Sripathi MS, Selvanayagam S, Velmurugan D, Murthy UD, Vishwas M, Thyagarajan SP, Raj SSS, Fun HK. Phyllanthin from the plants Phyllanthus amarus. Acta Crystallogr 2003;E59:203-205.
129. Dhalwal K, Biradar YS, Rajani M. High-performance thin-layer chromatography densitometric method for simultaneous quantitation of phyllanthin, hypophyllanthin, gallic acid, and ellagic acid in Phyllanthus amarus. J AOAC Int 2006;89(3):619-623.
130. Jayaram S, Thyagaragan SP, Sumathy S, Manjula S, Malathy S, Madanagopalan N. Efficiency of Phyllanthus amarus treatment in acute viral hepatitis A, B and non A and non B: An open clinical trial. Ind J Viorol 1997;13:59-64.
131. Thyagarajan SP, Thirunalasundari T, Subramanian S, Venkateswaran PS, Blumberg BS. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 1988;332(8614):764-766.
132. Prakas A, Satyan KS, Wahi SP, Singh RP. Comparative hepatoprotective activity of three Phyllanthus species, P. urinaria, P. niruri and P. simplex, on carbon tetrachloride induced liver injury in the rat. Phytother Res 1995;9:594-596.
133. Bhattacharjee R, Sil PC. The protein fraction of Phyllanthus niruri plays a protective role against acetoaminophen induced hepatic disorder via its antioxidant properties. Phytother Res 2006;20(7):595-601.
134. Lee CY, Peng WH, Cheng HY, Chen FN, Lai MT, Chiu TH. Hepatoprotective effect of Phyllanthus in Taiwan on acute liver damage induced by carbon tetrachloride. Am J Chin Med 2006;34(3):471-482.
135. Dixit SP, Achar MP. Bhunyamlaki (Phyllanthus niruri) and jaundice in children. J Natl Integ Med Ass 1983;25: 269-272.
136. Wang BE. Management of chronic hepatitis B: Treatment of chronic liver diseases with traditional Chinese medicine. J Gastroenterol Hepatol 2000;15 (Suppl):E67-E70.
137. Wang M, Haowei C, Yanjun L, Linmin M, Kai M, Chung-Kuo C. Observations of the efficacy of Phyllanthus spp. In treating patients with chronic hepatitis B. Yao TSA Chin 1994;19(12):750-752.
138. Syamsunder KV, Singh B, Thakur RS, Husain A, Kiso Y, Hikino H. Antihepatotoxic principles from Phyllanthus niruri herbs. J Ethnopharmacol 1985;14(1):41-44.
139. Bhattachrjee R, Sil PC. Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiacea), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties. Food Chem Toxicol 2007;45:817-826.
140. Joy KL, Kuttan R. Inhibition by Phyllanthus amarus of hepatocarcinogenesis induced by N-nitrosodiethyl amine. J Clin Biochem Nutr 1998;24:133-139.
141. Gowrishanker B, Vivekanandan OS. In vivo studies of a crude extract of Phyllanthus amarus L in modifying the genotoxicity induced in Vicia faba L by tannery effluents. Mutat Res 1994;322:185-192.
142. Adedapo AA, Adegbayibi AY, Emikpe BO. Some clinico-pathological changes associated with the aqueous extract of the leaves of Phyllanthus amarus in rats. Phytother Res 2005;19:971-976.
143. Levy C, Seeff LD, Lindor KD. Use of herbal supplements for chronic liver disease. Clin Gastrol Hepatol 2004;2:947-956.
144. Sabbioni C, Ferranti A, Bugamelli F, Forti GC, Raggi MA. Simultaneous HPLC analysis with isocratic elution of glycyrrhizin and glycyrrhetic acid in licorice root and confectionery products. Phytochem Anal 2006;17:25-31.
145. Raggi MA, Bugamelli F, Nobile L, et al. HPLC determination of glycyrrhizin and glycyrrhetic acid in biological fluids, after licorice extract administration to humans and rats. Boll Chim Farm 1994;133:704-708.
146. Chauhan SK, Singh BP, Kimothi GP, Agarwal S. Determination of glycyrrhizin in G. glabra and its extract by HPTLC. Ind J Pharm Sci 1998;60:251-252.
147. vanRossum TG, Vulto AG, deMan RA, Browner JT, Schalm SW. Glycyrrhizin as a potential treatment for chronic hepatitis C. Aliment Pharmacol Ther 1998;12:199-205.
148. Jeong HG, You HJ, Park SJ, Moon AR, Chung YC, Kang SK, Chun HK. Hepatoprotective effects of 18β-glycyrrhetinic acid on carbon tetrachloride induced liver injury: Inhibition of cytochrome P450 2E1 expression. Pharmacol Res 2002;46(3):221-227.
149. Kumada H. Long term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology 2002;62 (Suppl 1):94-100.
150. Xianshi S, Huiming C, Lizhuang W, Chuanfa J, Jianhui L. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis. J Tradit Chin Med 1984;4:127-132.
151. Akao T, Akao T, Hattori M, Kanaoka M, Yamamoto K, Namba T, Kobashi K. Hydrolysis of glycyrrhizin to glycyrrhetyl monoglucuronide by lysosomal beta-D-glucuronidase of animal livers. Biochem Pharmacol 1991;41:1025-1029.
152. Krahenbtihl S, Hasler F, Krapf R. Analysis and pharmacokinetics of glycyrrhizic acid and glycyrrhetinic acid in humans and experimental animals. Steroids 1994;59:121-126.
153. Takeda R, Morimoto S, Uchida K, Nakai T, Miyamoto M, Hashiba T, Yoshimitsu K, Kim S, Miwa U. Prolonged pseudoaldosteronism induced by glycyrrhizin. Endocrinol Jpn 1979;6:541-547.
154. Epstein M, Espiner E, Donald R, Hughes H. Effect of eating liquorice on the renninangiotension aldosterone axis in normal subjects. Br Med J 1977;1:488-490.
155. Chattopadhyay SK, Srivastava S, Negi AS, Saxena A. US Patent Appl. No. 20040191343.
156. Ray AB, Chattopadhyay SK. Structure of Cleomiscosin A, a coumarino-lignoid of Cleome viscosa seeds. Tetrahedron Lett 1980;21:4477-4480.
157. Ray AB, Chattopadhyay SK, Kumar S, Konno C, Kiso Y, Hikino H. Structures of Cleomiscosins, coumarino-lignoids of Cleome viscosa seeds. Tetrahedron 1985;41(1):209-214.
158. Annual Report of Central Institute of Medicinal and Aromatic Plants, Lucknow, India, 2006; 26.
159. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995;49:57-68.
160. Jeong HG. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: Hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett 1999;105:215-222.
161. Shukla B, Visen PKS, Patnaik GK, Tripathi SC, Srimal RC, Dayal R, Dobhal PC. Hepatoprotective activity in rat of ursolic acid isolated from Eucalyptus hybrid. Phytother Res 1992;6(2):74-79.
162. Marek R, Seckarova p, Hulova D, Marek J, Dostal J, Sklenar V. Palmatine and berberine isolation artifacts. J Nat Prod 2003;66:481-486.
163. Hwang JM, Wang CJ, Chou FP, Tseng TH, Hsieh YS, Lin WL, Chu CY. Inhibitory effect of berberine on tere-butyl hydroperoxide-induced oxidative damage in rat liver. Arch Toxicol 2002;76:664-670.
164. Janbaz KH, Gilani AH. Studies on preventive and curative effects of berberine on chemical induced hepatotoxicity in rodents. Fitoterapia 2000;71(1):25-33.
165. Wang F, Zhou HY, Zhao G, Fu LY, Cheng L, Chen JG, Yao WX. Inhibitory effects of berberine on ion channels of rat hepatocytes. World J Gastroenterol 2004;10(19):2842-2845.
166. Ip SP, Poom MK, Wu SS, Choe CT, Ng KH, Kong YC, Ko KM. Effect of schisandrin B on hepatic glutathione antioxidant system in mice: Protection against carbon tetrachloride toxicity. Planta Med 1995;61:398-401.
167. Lee KJ, Choi JH, Jeong HG. Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol 2007;45:2118-2125.
168. Molina MF, Sanchez-Reus I, Iglesias I, Benedi J. Quercetin, a flavonoids antioxidant, prevents and protects against ethanolinduced oxidative stress in mouse liver. Biol Pharm Bull 2003;26:1398-1402.
169. Preetha SP, Kanniappan M, Selvakumar E, Nagaraj M, Varalakshmi P. Lupeol ameliorates aflatoxin B1-induced peroxidative hepatic damage in rats. Comparative biochemistry and physiology: Part C. Toxicol Pharmacol 2006;143:333-339.
170. Rao MMG, Rao CV, Pushpangadan P, Shirwaikar A. Hepatoprotective effects of rubiadin, a major constituent of Rubia cordifolia Linn. J Ethnopharmacol 2006;103:484-490.
171. Janbaz KH, Saeed SA, Gilani AH. Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents. Phytomed 2004;11:424-430.
172. Kim HS, Lim HK, Chung MW, Kim YC. Antihepatotoxic activity of bergenin, the major constituent of Mallotus japonicus, on carbon tetrachloride-intoxicated hepatocytes. J Ethnopharmacol 2000;72:469-474.
173. Matsuda H, Ninomiya K, Shimoda H, Yoshikawa M. Hepatoprotective principles from the flowers of Tilia argentea (Linden): Structure requirements of tiliroside and mechanisms of action. Bioorg Med Chem 2002;10:707-712.
174. Iwu MM, Igboko OA, Onwuchekwa UA, Okunji CO. Evaluation of the antihepatotoxic activity of the biflavonoids of Garcinia kola seed. J Ethnopharmacol 1987;21:127-138.
175. Daba MH, Abdel-Rahman MS. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Lett 1998;95:23-29.
176. Matsude H, Murakami T, Ninomiya K, Inadzuki M, Yoshikawa M. New hepatoprotective saponins, bupleurosides III, VI, IX, and XIII, from Chinese Bupleuri radix: Structure-requirements for the cytoprotective activity in primary cultured rat hepatocytes. Bioorg Med Chem Lett 1997;7:2193-2198.
177. Lin CC, Chang CH, Yang JJ, Namba T, Hattori M. Hepatoprotective effects of emodin from Ventilago leiocarpa. J Ethnopharmacol 1996;52:107-111.
178. Morita T, Jinho K, Kawagishi H, Arimoto Y, Suganuma H, Inakuma T, Sugiyama K. Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans) on lipopolysaccharide/D-galactosamine-induced liver injury. J Agric Food Chem 2003;51:1560-1565.
179. Singh B, Chandan BK, Sharma N, Bhardwaj V, Satti NK, Gupta VN, Gupta BD, Suri KA, Suri OP. Isolation, Structure Elucidation and In Vivo Hepatoprotective Potential of trans-Tetracos-15-enoic acid from Indigofera tinctoria Linn. Phytother Res 2006;20:831-839.